Interventions for preventing oral mucositis for patients with cancer receiving treatment

HV Worthington, JE Clarkson, G Bryan… - Cochrane database …, 2011 - cochranelibrary.com
Background Treatment of cancer is increasingly more effective but is associated with short
and long term side effects. Oral side effects remain a major source of illness despite the use …

Role of antioxidants in cancer therapy

V Fuchs-Tarlovsky - Nutrition, 2013 - Elsevier
Oxidative stress is a key component in linking environmental toxicity to the multistage
carcinogenic process. Reactive oxygen species (ROS) are generated in response to both …

American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants

ML Hensley, KL Hagerty, T Kewalramani… - Journal of clinical …, 2009 - ascopubs.org
Purpose To update a clinical practice guideline on the use of chemotherapy and radiation
therapy protectants for patients with cancer. Methods An update committee reviewed …

NCCN task force report: prevention and management of mucositis in cancer care

W Bensinger, M Schubert, KK Ang, D Brizel… - Journal of the National …, 2008 - jnccn.org
Oral mucositis (OM) has emerged as a common cause of dose delays and interruptions of
cancer therapies such as multicycle chemotherapy, myeloablative chemotherapy, and …

Treatment of multiple myeloma and the role of melphalan in the era of modern therapies—Current research and clinical approaches

A Poczta, A Rogalska, A Marczak - Journal of clinical medicine, 2021 - mdpi.com
Multiple myeloma (MM) accounts for 10% of all hematological malignancies, and it is the
second most common hematological neoplasm for which chemotherapy is an important …

Clinacanthus nutans Extracts Are Antioxidant with Antiproliferative Effect on Cultured Human Cancer Cell Lines

YK Yong, JJ Tan, SS Teh, SH Mah… - Evidence‐Based …, 2013 - Wiley Online Library
Clinacanthus nutans Lindau leaves (CN) have been used in traditional medicine but the
therapeutic potential has not been explored for cancer prevention and treatment. Current …

[HTML][HTML] Putting evidence into practice®: evidence-based interventions for the management of oral mucositis

D Harris - Number 1/February 2008, 2008 - cjon.ons.org
Methods The team searched MEDLINE®, the US National Library of Medicine's
bibliographic database, CINAHL®(Cumulative Index to Nursing and Allied Health Literature) …

The effect of the use of thyme honey in minimizing radiation-induced oral mucositis in head and neck cancer patients: A randomized controlled trial

M Charalambous, V Raftopoulos, L Paikousis… - European Journal of …, 2018 - Elsevier
Purpose Radiation-induced oral mucositis is one of the main side effects during and after the
treatment of head and neck cancer patients. The study was designed to provide evidence on …

A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with …

K Lilleby, P Garcia, T Gooley, P McDonnnell… - Bone marrow …, 2006 - nature.com
Forty patients with multiple myeloma scheduled to receive melphalan 200 mg/m 2 followed
by autologous stem cell transplantation were randomly assigned to receive oral cryotherapy …

Systematic review of amifostine for the management of oral mucositis in cancer patients

O Nicolatou-Galitis, T Sarri, J Bowen… - Supportive Care in …, 2013 - Springer
Purpose The aim of this study was to review the available literature from 1966 until
December 31, 2010 and define clinical practice guidelines for the use of amifostine for the …